PomDoctor Ltd
POM0.243USD
+0.000+0.04%
收盤 02/02, 16:00（美東）報價延遲15分鐘
4.80M總市值
虧損本益比TTM
關於 PomDoctor Ltd 公司
PomDoctor Ltd is a company that mainly operates an online medical services platform for chronic diseases. The Company's business model focuses on chronic disease management and pharmaceutical services, forming a one-stop medical service platform that connects patients with doctors and pharmaceutical products. It helps patients to conveniently connect with doctors and obtain one-stop medical services.
PomDoctor Ltd簡介
公司代碼POM
公司名稱PomDoctor Ltd
上市日期Oct 08, 2025
CEOShi (Zhenyang)
員工數量156
證券類型Depository Receipt
年結日Oct 08
公司地址Yongxu Industrial Park
城市GUANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
國家China
郵編510000
電話862062312277
網址https://www.7lk.com/
公司代碼POM
上市日期Oct 08, 2025
CEOShi (Zhenyang)
PomDoctor Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Zhenyang Shi
Mr. Zhenyang Shi
Co-Founder, Chairman of the Board, Chief Executive Officer
Co-Founder, Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Xu
Ms. Li Xu
Co-Founder, Chief Financial Officer
Co-Founder, Chief Financial Officer
--
--
Mr. Guoji Luo
Mr. Guoji Luo
Vice President, Director Appointee
Vice President, Director Appointee
--
--
Mr. Dexiang Wei
Mr. Dexiang Wei
Vice President
Vice President
--
--
Ms. Yuanyuan Jing
Ms. Yuanyuan Jing
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Wenqing Bao
Mr. Wenqing Bao
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Daxue Li
Mr. Daxue Li
Independent Director Appointee
Independent Director Appointee
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Zhenyang Shi
Mr. Zhenyang Shi
Co-Founder, Chairman of the Board, Chief Executive Officer
Co-Founder, Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Xu
Ms. Li Xu
Co-Founder, Chief Financial Officer
Co-Founder, Chief Financial Officer
--
--
Mr. Guoji Luo
Mr. Guoji Luo
Vice President, Director Appointee
Vice President, Director Appointee
--
--
Mr. Dexiang Wei
Mr. Dexiang Wei
Vice President
Vice President
--
--
Ms. Yuanyuan Jing
Ms. Yuanyuan Jing
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Wenqing Bao
Mr. Wenqing Bao
Independent Director Appointee
Independent Director Appointee
--
--
收入明細
單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2024
FY2023
業務USD
名稱
營收
佔比
Prescription drugs
259.11M
75.64%
Over the counter(OTC)medicines
71.65M
20.92%
Traditional chinese medicine(TCM)
6.04M
1.76%
Others
4.38M
1.28%
Online consultaion
1.19M
0.35%
Mediccal apparatus and instruments(MAAI)
188.05K
0.05%
由於公司未披露，未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Prescription drugs
259.11M
75.64%
Over the counter(OTC)medicines
71.65M
20.92%
Traditional chinese medicine(TCM)
6.04M
1.76%
Others
4.38M
1.28%
Online consultaion
1.19M
0.35%
Mediccal apparatus and instruments(MAAI)
188.05K
0.05%
股東統計
更新時間: 2月1日 週日
更新時間: 2月1日 週日
持股股東
股東類型
持股股東
持股股東
佔比
UBS Financial Services, Inc.
0.21%
其他
99.79%
持股股東
持股股東
佔比
UBS Financial Services, Inc.
0.21%
其他
99.79%
股東類型
持股股東
佔比
Investment Advisor
0.21%
其他
99.79%
機構持股
更新時間: 2月1日 週日
更新時間: 2月1日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
1
221.26K
0.21%
+221.26K
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
暫無數據
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
